{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:16Z","timestamp":1792784896039,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003134","name":"Fonds pour la Formation \u00e0 la Recherche dans l\u2019Industrie et dans l\u2019Agriculture","doi-asserted-by":"publisher","award":["40021965)"],"award-info":[{"award-number":["40021965)"]}],"id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["J.0177.23"],"award-info":[{"award-number":["J.0177.23"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R\u00e9gion Wallonne, Belgium","award":["Orthenzy"],"award-info":[{"award-number":["Orthenzy"]}]},{"name":"R\u00e9gion Wallonne, Belgium","award":["Orthenzy"],"award-info":[{"award-number":["Orthenzy"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-026-00910-2","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:06:58Z","timestamp":1768540018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enzymes-enhanced antibiotic therapy reduces biofilms to undetectable levels in an implant-associated infection model"],"prefix":"10.1038","volume":"12","author":[{"given":"Randy","family":"Buzisa Mbuku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Poilvache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Maigret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Vanbever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"910_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1128\/CMR.00111-13","volume":"27","author":"AJ Tande","year":"2014","unstructured":"Tande, A. J. & Patel, R. Prosthetic joint infection. Clin. Microbiol. Rev. 27, 302\u2013345 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"910_CR2","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.arth.2017.11.029","volume":"33","author":"KL Urish","year":"2018","unstructured":"Urish, K. L. et al. A multicenter study of irrigation and debridement in total knee arthroplasty periprosthetic joint infection: treatment failure is high. J. Arthroplasty 33, 1154\u20131159 (2018).","journal-title":"J. Arthroplasty"},{"key":"910_CR3","doi-asserted-by":"publisher","first-page":"ofac492824","DOI":"10.1093\/ofid\/ofac492.824","volume":"9","author":"JM DeBiase","year":"2022","unstructured":"DeBiase, J. M., Day, S. R., Smith, J. M. & Agnello, S. 982. Microbiologic composition and failure rates of prosthetic hip and knee infections managed with debridement, antibiotics and implant retention. Open Forum Infect. Dis. 9, ofac492824 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"910_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1530\/EOR-23-0078","volume":"8","author":"Y Xu","year":"2023","unstructured":"Xu, Y., Huang, T. B., Schuetz, M. A. & Choong, P. F. M. Mortality, patient-reported outcome measures, and the health economic burden of prosthetic joint infection. EFORT Open Rev. 8, 690\u2013697 (2023).","journal-title":"EFORT Open Rev."},{"key":"910_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jiph.2015.12.014","volume":"9","author":"E Alp","year":"2016","unstructured":"Alp, E., Cevahir, F., Ersoy, S. & Guney, A. Incidence and economic burden of prosthetic joint infections in a university hospital: a report from a middle-income country. J. Infect. Public Health 9, 494\u2013498 (2016).","journal-title":"J. Infect. Public Health"},{"key":"910_CR6","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.arth.2017.03.066","volume":"32","author":"RE Delanois","year":"2017","unstructured":"Delanois, R. E. et al. Current epidemiology of revision total knee arthroplasty in the United States. J. Arthroplasty 32, 2663\u20132668 (2017).","journal-title":"J. Arthroplasty"},{"key":"910_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1055\/s-0033-1364102","volume":"27","author":"VK Aggarwal","year":"2014","unstructured":"Aggarwal, V. K. et al. Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States. J. Knee Surg. 27, 399\u2013406 (2014).","journal-title":"J. Knee Surg."},{"key":"910_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/jcm8050673","volume":"8","author":"N Benito","year":"2019","unstructured":"Benito, N. et al. The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms. J. Clin. Med. 8, 673 (2019).","journal-title":"J. Clin. Med."},{"key":"910_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/cid\/cis746","volume":"56","author":"J Lora-Tamayo","year":"2013","unstructured":"Lora-Tamayo, J. et al. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin. Infect. Dis. 56, 182\u2013194 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"910_CR10","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s40121-022-00701-0","volume":"11","author":"R Esp\u00edndola","year":"2022","unstructured":"Esp\u00edndola, R. et al. Rates and predictors of treatment failure in Staphylococcus aureus prosthetic joint infections according to different management strategies: a multinational cohort study\u2014the ARTHR-IS study group. Infect. Dis. Ther. 11, 2177\u20132203 (2022).","journal-title":"Infect. Dis. Ther."},{"key":"910_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.7150\/jbji.39168","volume":"4","author":"LH Barros","year":"2019","unstructured":"Barros, L. H. et al. Early debridement, antibiotics and implant retention (DAIR) in patients with suspected acute infection after hip or knee arthroplasty\u2014safe, effective and without negative functional impact. J. Bone Jt. Infect. 4, 300\u2013305 (2019).","journal-title":"J. Bone Jt. Infect."},{"key":"910_CR12","first-page":"636","volume":"86","author":"D Morcillo","year":"2020","unstructured":"Morcillo, D. et al. Debridement, antibiotics, irrigation and retention in prosthetic joint infection: predictive tools of failure. Acta Orthop. 86, 636\u2013643 (2020).","journal-title":"Acta Orthop."},{"key":"910_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/sur.2021.320","volume":"23","author":"M Bernaus","year":"2022","unstructured":"Bernaus, M. et al. Risk factors of DAIR failure and validation of the KLIC score: a multicenter study of four hundred fifty-five patients. Surg. Infect. 23, 280\u2013287 (2022).","journal-title":"Surg. Infect."},{"key":"910_CR14","doi-asserted-by":"publisher","first-page":"S463","DOI":"10.1016\/j.arth.2018.09.032","volume":"34","author":"R Anem\u00fcller","year":"2019","unstructured":"Anem\u00fcller, R. et al. Hip and knee section, treatment, antimicrobials: proceedings of international consensus on orthopedic infections. J. Arthroplasty 34, S463\u2013S475 (2019).","journal-title":"J. Arthroplasty"},{"key":"910_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jhin.2017.11.008","volume":"98","author":"WF Oliveira","year":"2018","unstructured":"Oliveira, W. F. et al. Staphylococcus aureus and Staphylococcus epidermidis infections on implants. J. Hosp. Infect. 98, 111\u2013117 (2018).","journal-title":"J. Hosp. Infect."},{"key":"910_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/BOT.0000000000001674","volume":"34","author":"PW Ferlic","year":"2020","unstructured":"Ferlic, P. W. et al. Increased Staphylococcus aureus biofilm formation on biodegradable poly(3-hydroxybutyrate)-implants compared with conventional orthopedic implants: an in vitro analysis. J. Orthop. Trauma 34, 210\u2013215 (2020).","journal-title":"J. Orthop. Trauma"},{"key":"910_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","volume":"358","author":"PS Stewart","year":"2001","unstructured":"Stewart, P. S. & Costerton, J. W. Antibiotic resistance of bacteria in biofilms. Lancet 358, 135\u2013138 (2001).","journal-title":"Lancet"},{"key":"910_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.569159","volume":"8","author":"T Ferry","year":"2021","unstructured":"Ferry, T. et al. Case Report: Arthroscopic \u201cdebridement antibiotics and implant retention\u201d with local injection of personalized phage therapy to salvage a relapsing Pseudomonas aeruginosa prosthetic knee infection. Front. Med. 8, 569159 (2021).","journal-title":"Front. Med."},{"key":"910_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31837-9","volume":"13","author":"T Ferry","year":"2022","unstructured":"Ferry, T. et al. Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection. Nat. Commun. 13, 4239 (2022).","journal-title":"Nat. Commun."},{"key":"910_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40121-024-01069-z","volume":"14","author":"M Golban","year":"2025","unstructured":"Golban, M., Charostad, J., Kazemian, H. & Heidari, H. Phage-derived endolysins against resistant Staphylococcus spp.: a review of features, antibacterial activities, and recent applications. Infect. Dis. Ther. 14, 13\u201357 (2025).","journal-title":"Infect. Dis. Ther."},{"key":"910_CR21","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1302\/2046-3758.1110.BJR-2021-0495.R3","volume":"11","author":"J Li","year":"2022","unstructured":"Li, J. et al. Current therapeutic interventions combating biofilm-related infections in orthopaedics. Bone Jt. Res. 11, 700\u2013714 (2022).","journal-title":"Bone Jt. Res."},{"key":"910_CR22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/antibiotics10121497","volume":"10","author":"KM Danis-Wlodarczyk","year":"2021","unstructured":"Danis-Wlodarczyk, K. M., Wozniak, D. J. & Abedon, S. T. Treating bacterial infections with bacteriophage-based enzybiotics: in vitro, in vivo and clinical application. Antibiotics 10, 1497 (2021).","journal-title":"Antibiotics"},{"key":"910_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2025.100288","volume":"9","author":"R Buzisa Mbuku","year":"2025","unstructured":"Buzisa Mbuku, R. et al. Targeting Staphylococcus aureus biofilm-related infections on implanted material with a novel dual-action thermosensitive hydrogel containing vancomycin and a tri-enzymatic cocktail: in vitro and in vivo studies. Biofilm 9, 100288 (2025).","journal-title":"Biofilm"},{"key":"910_CR24","doi-asserted-by":"publisher","first-page":"e01699","DOI":"10.1128\/AAC.01699-20","volume":"65","author":"H Poilvache","year":"2021","unstructured":"Poilvache, H., Ruiz-Sorribas, A., Cornu, O. & Van Bambeke, F. In-vitro study of the synergistic effect of an enzyme cocktail and antibiotics against biofilms in a prosthetic joint infection model. Antimicrob. Agents Chemother. 65, e01699\u201301620 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"910_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00427-y","volume":"9","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Strategy to combat biofilms: a focus on biofilm dispersal enzymes. NPJ Biofilms Microbiomes 9, 63 (2023).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"910_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0378-5173(99)00307-5","volume":"192","author":"ML Veyries","year":"1999","unstructured":"Veyries, M. L. et al. Controlled release of vancomycin from poloxamer 407 gels. Int. J. Pharm. 192, 183\u2013193 (1999).","journal-title":"Int. J. Pharm."},{"key":"910_CR27","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","volume":"23","author":"G Dumortier","year":"2006","unstructured":"Dumortier, G., Grossiord, J. L., Agnely, F. & Chaumeil, J. C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 23, 2709\u20132728 (2006).","journal-title":"Pharm. Res."},{"key":"910_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/pharmaceutics11120671","volume":"11","author":"E Russo","year":"2019","unstructured":"Russo, E. & Villa, C. Poloxamer hydrogels for biomedical applications. Pharmaceutics 11, 671 (2019).","journal-title":"Pharmaceutics"},{"key":"910_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2017.e00390","volume":"3","author":"A Fakhari","year":"2017","unstructured":"Fakhari, A., Corcoran, M. & Schwarz, A. Thermogelling properties of purified poloxamer 407. Heliyon 3, e00390 (2017).","journal-title":"Heliyon"},{"key":"910_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.chom.2019.06.002","volume":"26","author":"J Yan","year":"2019","unstructured":"Yan, J. & Bassler, B. L. Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms. Cell Host Microbe 26, 15\u201321 (2019).","journal-title":"Cell Host Microbe"},{"key":"910_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/17425247.2020.1731469","volume":"17","author":"H Abdeltawab","year":"2020","unstructured":"Abdeltawab, H., Svirskis, D. & Sharma, M. Formulation strategies to modulate drug release from poloxamer based in situ gelling systems. Expert Opin. Drug Deliv. 17, 495\u2013509 (2020).","journal-title":"Expert Opin. Drug Deliv."},{"key":"910_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.curtheres.2019.100569","volume":"91","author":"P Vincent","year":"2019","unstructured":"Vincent, P. Injections intra articulaires (IA) d\u2019acide hyaluronique (AH) dans le traitement symptomatique de la gonarthrose: une m\u00e9ta-analyse des injections uniques (mono-injections). Curr. Ther. Res. Clin. Exp. 91, 52\u201365 (2019).","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"910_CR33","first-page":"e73210","volume":"16","author":"H Mills","year":"2024","unstructured":"Mills, H., Donnelly, L., Platt, S. & Platt, S. R. Locally delivered antibiotics in fracture-related infection. Cureus 16, e73210 (2024).","journal-title":"Cureus"},{"key":"910_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107359","volume":"64","author":"N Kobayashi","year":"2024","unstructured":"Kobayashi, N. et al. Effectiveness of rifampicin combination therapy for orthopedic implant-related infections: a systematic review and meta-analysis. Int. J. Antimicrob. Agents 64, 107359 (2024).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"910_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","volume":"81","author":"AK Thabit","year":"2019","unstructured":"Thabit, A. K. et al. Antibiotic penetration into bone and joints: an updated review. Int. J. Infect. Dis. 81, 128\u2013136 (2019).","journal-title":"Int. J. Infect. Dis."},{"key":"910_CR36","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1128\/AAC.00181-13","volume":"57","author":"J Bauer","year":"2013","unstructured":"Bauer, J., Siala, W., Tulkens, P. M. & Van Bambeke, F. A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 57, 2726\u20132737 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"910_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature12790","volume":"503","author":"BP Conlon","year":"2013","unstructured":"Conlon, B. P. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503, 365\u2013370 (2013).","journal-title":"Nature"},{"key":"910_CR38","unstructured":"International Organization for Standardization. ISO 10993-5:2009. Biological Evaluation of Medical Devices\u2014Part 5: Tests for In Vitro Cytotoxicity (ISO, 2009)."},{"key":"910_CR39","unstructured":"OECD. OECD Test No. 439: In Vitro Skin Irritation: Reconstructed Human Epidermis (RHE) Test Method (OECD, 2015)."},{"key":"910_CR40","unstructured":"International Organization for Standardization. ISO 10993-1:2018. Biological Evaluation of Medical Devices\u2014Part 1: Evaluation and Testing within a Risk Management Process (ISO, 2018)."},{"key":"910_CR41","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fmed.2020.00527","volume":"7","author":"H Poilvache","year":"2020","unstructured":"Poilvache, H. et al. Synergistic effects of pulsed lavage and antimicrobial therapy against Staphylococcus aureus biofilms in an in-vitro model. Front. Med. 7, 527 (2020).","journal-title":"Front. Med."},{"key":"910_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/infdis\/119.2.132","volume":"119","author":"CM Kunin","year":"1969","unstructured":"Kunin, C. M., Brandt, D. & Wood, H. Bacteriologic studies of rifampin, a new semisynthetic antibiotic. J. Infect. Dis. 119, 132\u2013137 (1969).","journal-title":"J. Infect. Dis."},{"key":"910_CR43","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/jac\/39.6.817","volume":"39","author":"E Svensson","year":"1997","unstructured":"Svensson, E., Hanberger, H., Nilsson, M. & Nilsson, L. E. Factors affecting development of rifampicin resistance in biofilm-producing Staphylococcus epidermidis. J. Antimicrob. Chemother. 39, 817\u2013820 (1997).","journal-title":"J. Antimicrob. Chemother."},{"key":"910_CR44","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 14.0. http:\/\/www.eucast.org (2024)."},{"key":"910_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/jac\/dkac428","volume":"78","author":"S Bae","year":"2023","unstructured":"Bae, S. et al. Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia. J. Antimicrob. Chemother. 78, 531\u2013539 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"910_CR46","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3389\/fmicb.2017.01401","volume":"8","author":"M Sabat\u00e9 Bresc\u00f3","year":"2017","unstructured":"Sabat\u00e9 Bresc\u00f3, M. et al. Pathogenic mechanisms and host interactions in Staphylococcus epidermidis device-related infection. Front. Microbiol. 8, 1401 (2017).","journal-title":"Front. Microbiol."},{"key":"910_CR47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/jbm.b.34703","volume":"109","author":"MC Beard","year":"2021","unstructured":"Beard, M. C. et al. Autoclaving of Poloxamer 407 hydrogel and its use as a drug delivery vehicle. J. Biomed. Mater. Res. B Appl. Biomater. 109, 338\u2013347 (2021).","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"910_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijpharm.2004.09.028","volume":"288","author":"EJ Ricci","year":"2005","unstructured":"Ricci, E. J., Lunardi, L. O., Nanclares, D. M. & Marchetti, J. M. Sustained release of lidocaine from Poloxamer 407 gels. Int. J. Pharm. 288, 235\u2013244 (2005).","journal-title":"Int. J. Pharm."},{"key":"910_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/pharmaceutics10030159","volume":"10","author":"E Giuliano","year":"2018","unstructured":"Giuliano, E., Paolino, D., Fresta, M. & Cosco, D. Mucosal applications of Poloxamer 407-based hydrogels: an overview. Pharmaceutics 10, 159 (2018).","journal-title":"Pharmaceutics"},{"key":"910_CR50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","volume":"58","author":"E Ruel-Gari\u00e9py","year":"2004","unstructured":"Ruel-Gari\u00e9py, E. & Leroux, J. C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 58, 409\u2013426 (2004).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"910_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/10837450.2018.1425431","volume":"24","author":"J Li","year":"2019","unstructured":"Li, J., Rudraraju, S., Zheng, S. & Jaiswal, A. Adsorption of polypropylene oxide-polyethylene oxide type surfactants at surfaces of pharmaceutical relevant materials: effect of surface energetics and surfactant structures. Pharm. Dev. Technol. 24, 70\u201379 (2019).","journal-title":"Pharm. Dev. Technol."},{"key":"910_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0927-7757(94)03028-X","volume":"96","author":"P Alexandridis","year":"1995","unstructured":"Alexandridis, P. & Alan Hatton, T. Poly(ethylene oxide) poly(propylene oxide) poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. Colloids Surf. A Physicochem. Eng. Asp. 96, 1\u201346 (1995).","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"910_CR53","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/polym15112465","volume":"15","author":"N Hirun","year":"2023","unstructured":"Hirun, N., Kraisit, P. & Soontaranon, S. Role of bovine serum albumin addition in micellization and gel formation of Poloxamer 407. Polymers 15, 2465 (2023).","journal-title":"Polymers"},{"key":"910_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/antibiotics11040486","volume":"11","author":"B Le Vavasseur","year":"2022","unstructured":"Le Vavasseur, B. & Zeller, V. Antibiotic therapy for prosthetic joint infections: an overview. Antibiotics 11, 486 (2022).","journal-title":"Antibiotics"},{"key":"910_CR55","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.3390\/jcm13164848","volume":"13","author":"A Jarusriwanna","year":"2024","unstructured":"Jarusriwanna, A., Mu, W. & Parvizi, J. Local antibiotic infusion in periprosthetic joint infection following total hip arthroplasty. J. Clin. Med. 13, 4848 (2024).","journal-title":"J. Clin. Med."},{"key":"910_CR56","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/antibiotics12040752","volume":"12","author":"W Steadman","year":"2023","unstructured":"Steadman, W. et al. Local antibiotic delivery options in prosthetic joint infection. Antibiotics 12, 752 (2023).","journal-title":"Antibiotics"},{"key":"910_CR57","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/jor.20214","volume":"24","author":"P-H Hsieh","year":"2006","unstructured":"Hsieh, P.-H., Chang, Y.-H., Chen, S.-H., Ueng, S. W.-N. & Shih, C.-H. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex\u2122 cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J. Orthop. Res. 24, 1615\u20131621 (2006).","journal-title":"J. Orthop. Res."},{"key":"910_CR58","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/antibiotics13060538","volume":"13","author":"L Prats-Peinado","year":"2024","unstructured":"Prats-Peinado, L. et al. Do high doses of multiple antibiotics loaded into bone cement spacers improve the success rate in staphylococcal periprosthetic joint infection when rifampicin cannot be employed? Antibiotics 13, 538 (2024).","journal-title":"Antibiotics"},{"key":"910_CR59","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.arth.2016.11.042","volume":"32","author":"F Amerstorfer","year":"2017","unstructured":"Amerstorfer, F. et al. Superficial vancomycin coating of bone cement in orthopedic revision surgery: a safe technique to enhance local antibiotic concentrations. J. Arthroplasty 32, 1618\u20131624 (2017).","journal-title":"J. Arthroplasty"},{"key":"910_CR60","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1302\/0301-620X.105B3.BJJ-2022-0926.R1","volume":"105-B","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. One-stage revision using intra-articular carbapenem infusion effectively treats chronic periprosthetic joint infection caused by Gram-negative organisms. Bone Jt. J. 105-B, 284\u2013293 (2023).","journal-title":"Bone Jt. J."},{"key":"910_CR61","doi-asserted-by":"publisher","first-page":"e0232775","DOI":"10.1371\/journal.pone.0232775","volume":"15","author":"S Nikinmaa","year":"2020","unstructured":"Nikinmaa, S. et al. Dual-light photodynamic therapy administered daily provides a sustained antibacterial effect on biofilm and prevents Streptococcus mutans adaptation. PLoS ONE 15, e0232775 (2020).","journal-title":"PLoS ONE"},{"key":"910_CR62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pdpdt.2015.06.004","volume":"12","author":"K Marinic","year":"2015","unstructured":"Marinic, K. et al. Repeated exposures to blue light-activated eosin Y enhance inactivation of E. faecalis biofilms, in vitro. Photodiagn. Photodyn. Ther. 12, 393\u2013400 (2015).","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"910_CR63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1600-0722.2007.00419.x","volume":"115","author":"S Fraud","year":"2007","unstructured":"Fraud, S., Maillard, J.-Y., Denyer, S. P., Kaminski, M. A. & Hanlon, G. W. A simulated oral hygiene model to determine the efficacy of repeated exposure of amine oxide on the viability of Streptococcus mutans biofilms. Eur. J. Oral. Sci. 115, 71\u201376 (2007).","journal-title":"Eur. J. Oral. Sci."},{"key":"910_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1435720","volume":"15","author":"L Ferreira","year":"2024","unstructured":"Ferreira, L. et al. Antibiotics with antibiofilm activity\u2014rifampicin and beyond. Front. Microbiol. 15, 1435720 (2024).","journal-title":"Front. Microbiol."},{"key":"910_CR65","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s13018-020-01877-2","volume":"15","author":"\u00d8 Karlsen","year":"2020","unstructured":"Karlsen, \u00d8 et al. Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial. J. Orthop. Surg. Res. 15, 365 (2020).","journal-title":"J. Orthop. Surg. Res."},{"key":"910_CR66","doi-asserted-by":"publisher","first-page":"ftw019","DOI":"10.1093\/femspd\/ftw019","volume":"74","author":"NP J\u00f8rgensen","year":"2016","unstructured":"J\u00f8rgensen, N. P. et al. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro. Pathog. Dis. 74, ftw019 (2016).","journal-title":"Pathog. Dis."},{"key":"910_CR67","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1128\/AAC.00134-09","volume":"53","author":"KL LaPlante","year":"2009","unstructured":"LaPlante, K. L. & Woodmansee, S. B. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob. Agents Chemother. 53, 3880\u20133886 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"910_CR68","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/jac\/dkn513","volume":"63","author":"WE Rose","year":"2009","unstructured":"Rose, W. E. & Poppens, P. T. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J. Antimicrob. Chemother. 63, 485\u2013488 (2009).","journal-title":"J. Antimicrob. Chemother."},{"key":"910_CR69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jiac.2016.02.011","volume":"22","author":"J Hirai","year":"2016","unstructured":"Hirai, J. et al. Investigation on rifampicin administration from the standpoint of pharmacokinetics\/pharmacodynamics in a neutropenic murine thigh infection model. J. Infect. Chemother. 22, 387\u2013394 (2016).","journal-title":"J. Infect. Chemother."},{"key":"910_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00552-2","volume":"10","author":"B Chen","year":"2024","unstructured":"Chen, B. et al. Combination of bacteriophages and vancomycin in a co-delivery hydrogel for localized treatment of fracture-related infections. NPJ Biofilms Microbiomes 10, 77 (2024).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"910_CR71","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1016\/j.bmc.2016.11.008","volume":"24","author":"M Zhao","year":"2016","unstructured":"Zhao, M., Lepak, A. J. & Andes, D. R. Animal models in the pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents. Bioorg. Med. Chem. 24, 6390\u20136400 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"910_CR72","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/jbm.820060609","volume":"6","author":"IR Schmolka","year":"1972","unstructured":"Schmolka, I. R. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res. 6, 571\u2013582 (1972).","journal-title":"J. Biomed. Mater. Res."},{"key":"910_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz032","volume":"6","author":"II Geneva","year":"2019","unstructured":"Geneva, I. I., Cuzzo, B., Fazili, T. & Javaid, W. Normal body temperature: a systematic review. Open Forum Infect. Dis. 6, ofz032 (2019).","journal-title":"Open Forum Infect. Dis."},{"key":"910_CR74","unstructured":"ASTM International. ASTM F813 (2019). Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices. https:\/\/jp.astm.org\/industry\/medical-device\/ (2019)."},{"key":"910_CR75","unstructured":"International Organization for Standardization. ISO 10993-23:2021. Biological Evaluation of Medical Devices\u2014Part 23: Tests for Irritation (ISO, 2021)."},{"key":"910_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2023.1337468","volume":"5","author":"H Kan\u010f\u00e1rov\u00e1","year":"2023","unstructured":"Kan\u010f\u00e1rov\u00e1, H. & P\u00f4bi\u0161, P. The \u201cBig Three\u201d in biocompatibility testing of medical devices: implementation of alternatives to animal experimentation-are we there yet? Front. Toxicol. 5, 1337468 (2023).","journal-title":"Front. Toxicol."},{"key":"910_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105371","volume":"82","author":"C Pellevoisin","year":"2022","unstructured":"Pellevoisin, C., Coleman, K. P. & Hoffmann, S. ISO 10993-23 In vitro irritation testing for medical devices: substantiating applicability to mild irritants and non-extractables. Toxicol. Vitr. 82, 105371 (2022).","journal-title":"Toxicol. Vitr."},{"key":"910_CR78","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/infdis\/146.4.487","volume":"146","author":"W Zimmerli","year":"1982","unstructured":"Zimmerli, W., Waldvogel, F. A., Vaudaux, P. & Nydegger, U. E. Pathogenesis of foreign body infection: description and characteristics of an animal model. J. Infect. Dis. 146, 487\u2013497 (1982).","journal-title":"J. Infect. Dis."},{"key":"910_CR79","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/BF03546916","volume":"25","author":"B Bengtsson","year":"1984","unstructured":"Bengtsson, B., Luthman, J. & Jacobsson, S. O. Evaluation of a tissue cage model for use in cattle. Acta Vet. Scand. 25, 480\u2013494 (1984).","journal-title":"Acta Vet. Scand."},{"key":"910_CR80","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/ten.teb.2012.0059","volume":"18","author":"RB de Vries","year":"2012","unstructured":"de Vries, R. B., Buma, P., Leenaars, M., Ritskes-Hoitinga, M. & Gordijn, B. Reducing the number of laboratory animals used in tissue engineering research by restricting the variety of animal models. Articular cartilage tissue engineering as a case study. Tissue Eng. B Rev. 18, 427\u2013435 (2012).","journal-title":"Tissue Eng. B Rev."},{"key":"910_CR81","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/jmcc.1998.0655","volume":"30","author":"BK Slinker","year":"1998","unstructured":"Slinker, B. K. The statistics of synergism. J. Mol. Cell Cardiol. 30, 723\u2013731 (1998).","journal-title":"J. Mol. Cell Cardiol."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00910-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00910-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00910-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:03:51Z","timestamp":1770901431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00910-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["910"],"URL":"https:\/\/doi.org\/10.1038\/s41522-026-00910-2","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Onelife provided the enzymatic cocktail used in this study and contributed to cover the functioning costs of this study, without intervening in the design of the study, the interpretation of the data or the writing of the paper. Prof. Van Bambeke has been named among the inventors of the international Patent Application WO2022079315, assigned to OneLife and UCL. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}